Tarzana, CA, United States of America

Immunocellular Therapeutics, Ltd.

Calculating rank
USPTO Granted Patents = 8

% Expired Patents = 62.5


Forward Citations = 59

Loading Chart...
Loading Chart...

4 inventors (with patents filed for the assignee):

goldMedal Cohava Gelber (5 out of 10 patents)

silverMedal James Bender (3 out of 71 patents)

bronzeMedal Manish Singh (2 out of 2 patents)

4.  John S Yu (1 out of 23 patents)

5.  James G Bender (0 patent)


8 patents:

Company Overview
Immunocellular Therapeutics, Ltd. is a clinical-stage biotechnology company focused on developing and commercializing innovative immunotherapies for the treatment of cancer. The company's lead product candidate, ICT-107, is a personalized dendritic cell-based cancer vaccine that is being evaluated in phase 3 clinical trials for the treatment of glioblastoma multiforme, a type of brain cancer. Immunocellular Therapeutics is dedicated to harnessing the power of the immune system to combat cancer and improve patient outcomes.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

Immunocellular Therapeutics, Ltd. USPTO Patent Assignee Logo
8 Patents

#3 in Tarzana, CA

#8,545 in California

#35,954 in US

Tarzana, CA (US)
Tarzana, CA, United States of America
Forward Citations = 59

4 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Immunocellular Therapeutics, Ltd.. Retrieved from https://idiyas.com/company/immunocellular-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…